Program in Global Oncology

HIV-Associated Malignancy Training Program

Nurse draws blood sample from patient

Nurse Janet Nankoma Kwiri of the Uganda Cancer Institute tends to patient Ojambo Samwiri of Nyenga-Mukono, Uganda, who is receiving treatment for the Kaposi sarcoma on his lower limbs. (Photo by Rob Gipman, UCI/Hutchinson Center Cancer Alliance)

The HIV-Associated Malignancy Training Program (HAMTP) is supplemented by funds from the University of Washington International AIDS Research Training Program (IARTP) and Fred Hutch. This program augments the exceptional strengths of the preexisting program in HIV with a preeminent program in oncology education and research. Thus the structure of this training program adds to the existing infrastructure of the UW IARTP a specialized component on HIV malignancies as described below. One of the key strengths of the UW IARTP Program on HIV-Associated Malignancies is the integration of partners with outstanding histories in research and training in both HIV and cancer. These partners include the UW IARTP parent program, the Hutch, and the Uganda Cancer Institute (UCI).

HAMTP Training Goals

  1. Enhance the education of U.S. and Ugandan physician-scientists.
  2. Conduct cutting edge research in infection associated cancers.
  3. Improve the care of Ugandans with cancer.

Program specific aims

  1. To provide didactic training in the epidemiology and pathophysiology of HIV-associated malignancies through focused coursework and individual mentorships in public health, molecular biology, cancer pathogenesis, epidemiologic and translational clinical research.
  2. To expose Ugandan physician-scientists to the current needs in diagnosis, prevention and treatment of HIV-associated malignancies through integration into an existing postgraduate oncology training program at FHCRC tailored specifically for Ugandan physicians.
  3. To foster the development of the next generation of African investigators in HIV-associated malignancy translational clinical research by providing training in the conduct of translational research, including clinical trials, and establishment of collaborative research projects to be conducted in Uganda.

Scheduled Scholar Training

This program consists of six 12-month certificate-earning trainees and one two-year MPH-earning trainee, leading to a significant increase in research capacity in Uganda upon the trainees’ return home. The trainee in the MPH Program track will follow in a track established by MPH candidates in the IARTP parent program. The goal of this training is to produce competent investigators who will return to their home countries to continue collaborative HIV-associated malignancy research and become influential, independent investigators.

Completed Training 

  • Victoria Walusansa – 1-year HAMTP/IARTP certificate (2007-2008)
  • Amos Mwaka – 1-year HAMTP/IARTP certificate (2008-2009)
  • Fred Okuku – HAMTP/IARTP certificate (2009-2010)
    Innocent Mutyaba – HAMTP/IARTP certificate (2009-2010)

Current Trainees

  • Noleb Mugisha – 2-year MPH program (2010-2012)
  • Abrams Omoding – HAMTP/IARTP certificate (2010-2011)

Future Trainee 

  • Anthony Natif – 1 year pharmacy certificate (2011-2012)